Annie Séguin

698 total citations · 1 hit paper
3 papers, 394 citations indexed

About

Annie Séguin is a scholar working on Biotechnology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Annie Séguin has authored 3 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Biotechnology, 2 papers in Infectious Diseases and 1 paper in Molecular Biology. Recurrent topics in Annie Séguin's work include Transgenic Plants and Applications (3 papers), Viral gastroenteritis research and epidemiology (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). Annie Séguin is often cited by papers focused on Transgenic Plants and Applications (3 papers), Viral gastroenteritis research and epidemiology (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). Annie Séguin collaborates with scholars based in Canada. Annie Séguin's co-authors include Sonia Trépanier, Nathalie Landry, Brian J. Ward, Stéphane Pillet, А. И. Макарков, Timo Vesikari, Michael Libman, Carolyn Finkle, Manon Couture and Iohann Boulay and has published in prestigious journals such as The Lancet, Nature Medicine and Vaccine.

In The Last Decade

Annie Séguin

3 papers receiving 390 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19

2021 214 citations Brian J. Ward, Philipe Gobeil et al. Nature Medicine profile →

Peers

Annie Séguin

BIOTE

ID

MB

IMMUN

PS

А. И. Макарков Canada

Fabienne B. Bouche Luxembourg

Srijita Basak India

Elissa Hudspeth United States

Vikram Virdi Belgium

Maggie Lewis United States

Ernie Hiatt United States

Debashrito Deb India

Debbie Stewart South Africa

Utkarsh Narsaria India

А. И. Макарков Canada

Annie Séguin

227 ×1.1

BIOTE

199 ×1.1

ID

188 ×1.0

MB

130 ×1.1

IMMUN

68 ×1.1

PS

Citations per year, relative to Annie Séguin Annie Séguin (= 1×) peers А. И. Макарков

Countries citing papers authored by Annie Séguin

Since Specialization

Citations

This map shows the geographic impact of Annie Séguin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Séguin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Séguin more than expected).

Fields of papers citing papers by Annie Séguin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Séguin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Séguin. The network helps show where Annie Séguin may publish in the future.

Co-authorship network of co-authors of Annie Séguin

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Séguin. A scholar is included among the top collaborators of Annie Séguin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Séguin. Annie Séguin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Ward, Brian J., Philipe Gobeil, Annie Séguin, et al.. (2021). Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19. Nature Medicine. 27(6). 1071–1078. 214 indexed citations breakdown →

2.

Ward, Brian J., et al.. (2021). Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18–49 years of age. Vaccine. 39(10). 1528–1533. 48 indexed citations

3.

Ward, Brian J., А. И. Макарков, Annie Séguin, et al.. (2020). Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials. The Lancet. 396(10261). 1491–1503. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact